The Big Pharma is paying up to $1.5 billion, split between an upfront fee and a milestone payment, to buy shingles vaccine ...
The Food and Drug Administration’s (FDA) advisory committee on vaccines this week will consider whether to change the ...
LYON, France & KUMAMOTO, Japan--(BUSINESS WIRE)--Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating respiratory viruses, and KM ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
Here at Focus, we've been closely following the effects of the government shutdown on the US Food and Drug Administration's (FDA) operations. And so have some legislators, by the looks of it. That ...
Declaring that the number of vaccine producers has "plummeted" as "the industry has been flooded with lawsuits, President Bush said Tuesday that granting vaccine manufacturers protection from civil ...
The FDA is meeting later this week to decide which variant the 2026-27 COVID vaccine will target. The WHO recommended ...
DES MOINES — Federal legal protections added in the 1980s to shield vaccine manufacturers from most lawsuits would be waived any time a vaccine is administered in Iowa under legislation that was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results